HC Surgical Specialists (SGX:1B1) completed the acquisition of Chirurgia, according to a Tuesday filing with the Singapore Exchange.
The medical services group had earlier signed a deal to acquire a 51% stake in Chirurgia for SG$1.2 million.
Chirurgia provides minimally invasive surgery and treatment for gallbladder diseases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments